Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

Vladimir Petenev

News editor

Write your comment first

News feed

Yesterday at 22:54 LSNG

Yesterday at 17:38 LVHK

Yesterday at 17:13 TATN

Yesterday at 17:08 MVID

Yesterday at 15:41 LVHK

Yesterday at 15:05 MTSS

Yesterday at 14:48 NAUK

Yesterday at 14:46 NAUK

Yesterday at 13:26 MGKL

Yesterday at 13:06 SVAV